Post-HSCT management of paediatric patients with ALL

Should every transplant eligible NDMM patient receive a transplant?

The clinical value of maintenance in multiple myeloma

Reduced intensity allogeneic HSCT to hypomethylating therapy or best supportive care in older patients with advanced MDS

Escalation and descalation in neoadjuvant time to treatment of TNBC

OncoAlert Colloquium Day 5: Genitourinary tumours and social media

OncoAlert Colloquium Day 4: Gynae-oncology, lymphoma, sarcoma and melanoma

OncoAlert Colloquium Day 3: Breast cancer

Decitabine plus ipilimumab in r/r MDS/AML in the post-BMT or transplant naïve settings

Five year update of ECHELON-1 for classical Hodgkin lymphoma

Real world management of multiple myeloma patients

OncoAlert and ecancer weekly roundup for November 15 - 21, 2020